Indivior PLC
Indivior PLC (INVVY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INVVY · as of Jun 8, 2026
Key Statistics
Explore Indivior PLC Data
invvy stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
The INVVY analyst consensus is Hold, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $50.00, representing +128.88% upside from the current price of $21.85.
Competitors & Peers
invvy competitorsINVVY
ARHCF
ASPHF
DUTV
GALNF
KARBFStock Performance
Full HistoryAbout Indivior PLC
Indivior PLC encompassing its various subsidiaries, is a pharmaceutical firm dedicated to the research, production, and global commercialization of prescription medications. These therapies primarily…
what is indivior plc · invvy stock overview · indivior plc company profile · who is indivior plc ceo · invvy OTC · indivior plc headquarters · indivior plc business segments
About Stock Overview & Key Data
Indivior PLC (INVVY) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jun 9, 2015. As of the latest trading session, INVVY stock price is $21.85, with a market capitalization of $3.0B. The stock has returned +19.37% over the past 12 months and -3.42% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Indivior PLC stock is Hold, with an average 12-month price target of $50.00. In fiscal year 2022, Indivior PLC reported revenue of $901.0M and net income of -$53.0M. For detailed data — including Indivior PLC revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Indivior PLC (INVVY) stock price is $21.85. The stock is traded on OTC under the ticker symbol INVVY. The 52-week range is $14.76 – $75.65.